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Abstract: Chlamydia psittaci causes psittacosis in humans, mainly in people in contact with birds
in either the setting of occupational or companion bird exposure. Infection is associated with a
range of clinical manifestations from asymptomatic infection to severe atypical pneumonia and
systemic disease. C. psittaci has also been associated with ocular adnexal lymphoma in human
patients. The current paper describes successful doxycycline treatment of a male patient suffering
from C. psittaci chronic unilateral conjunctivitis, most probably linked to the visit of a South African
wildlife reserve. Increased awareness among general and occupational physicians, ophthalmologists,
clinicians, and the public on the potential of C. psittaci to cause ocular infection is needed.
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1. Case Description
A 57 year old Caucasian man with a blank past medical history presented at the eye clinic in 2016
with a history of a unilateral swollen eyelid and red right eye. His medical complaints started during
a 10-day trip to South Africa, two days after visiting False Bay. Initially, the patient was treated in
South Africa by a local general practitioner with oral azithromycin 500 mg for 3 days together with
topical dexamethasone/tobramycin eye drops. After an initial improvement, 14 days later conjunctivitis
symptoms flared up severely when skiing in Switzerland. Upon return to his home country, the patient
consulted the eye clinic.
2. Medical Examination and Treatment
Day 1. Clinical examination showed a best-corrected visual acuity of 6/7.5 for the right eye
and 6/6 for the left eye. On slit-lamp examination, primary follicles in the fornix with conjunctival
hyperemia were observed. Corneal punctate epithelial keratopathy was not observed, and Tyndall
effect and white blood cells were absent. The intra-ocular pressure and fundoscopy were without
any abnormalities. A swab (E-swab, Liquid Amies, Copan, Italy) of the lower tarsal conjunctivae was
taken. Additionally, a sample from a crust on the eye was taken. Bacterial culture of the individual
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ocular samples and molecular detection for Chlamydia trachomatis/Neisseria gonorrhoeae (BD MAX
CT/GC/TV, Becton Dickinson, Franklin Lakes, NJ, USA), Herpes simplex (HSV)/Varicella Zoster (BD
MAX HSV1/HSV2/VZV, Becton Dickinson, Franklin Lakes, NJ, USA), and Epstein Barr virus (EBV)
on the pooled ocular sample [1] were performed. Treatment with aciclovir 800 mg, 5 times per day,
was started.
Day 5. The patient returned after five days with deteriorated vision and worsening of the redness
of his eye. The best-corrected visual acuity was 6/6 in both eyes. At that point, slit-lamp examination
showed new ulcerated lesions at the eyelid margin. Blood analysis showed no abnormalities,
apart from a slightly elevated C-reactive protein (22 mg/dl). Viral/bacterial serology was negative for
Cytomegalovirus, HSV, andBorrelia burgdorferi; and positive for EBV and Varicella Zoster (VZV). With all
the above microbiological detection methods remaining negative, acyclovir treatment was discontinued.
One Month after the First Visit
Symptoms did not disappear, and the patient consulted two other ophthalmologists and ultimately,
an infectious disease physician at a travel clinic in the following weeks. A second course of 6 days
azithromycin, combined with fluoroquinolone (ofloxacin) eye drops showed no improvement. At that
point the patient also mentioned suffering from influenza-like symptoms (arthralgia and myalgia)
at night, albeit without fever or respiratory distress. One month after the first visit, he presented
back at the original eye clinic. In consultation with the infectiologist and following a thorough travel
anamnesis, the patient reported to have visited a wildlife reserve in Boulders Beach, South Africa
where birds and African penguins were present. As such, the possibility of conjunctivitis caused by
Chlamydia psittaci was taken into consideration. Supplementary testing on the pooled ocular sample
taken during the first visit (ocular E-swab in Liquid Amies transport medium and a sample from a crust
on the eye) using a C. psittaci-specific nested PCR [2] revealed a positive result. A genotype-specific
real-time PCR targeting the gene encoding the outer membrane protein A (ompA), confirmed the
presence of C. psittaci genotype B [3]. However, a serological response to C. psittaci (Anti-Chlamydia
HP Euroline-WB Ig, Euroimmun, Lubeck, Germany) could not be detected. A chest radiograph to
exclude signs of consolidation, a frequent manifestation of psittacosis, was negative. The patient was
successfully treated with doxycycline 100 mg twice daily for two weeks, after which all symptoms were
resolved. For publication of case study descriptions, an informed consent was signed by the patient.
3. Discussion
One of the most typical pathogens associated with chronic unilateral conjunctivitis is C. trachomatis,
but as demonstrated by the present case, C. psittaci should also be taken into consideration as
a causative agent. Members of the genus Chlamydiaceae are obligate intracellular gram-negative
bacteria that are able to cause a variety of acute and chronic infections in humans, other mammals,
and birds. While C. trachomatis and C. pneumoniae are typical human pathogens, other Chlamydia
species predominantly cause zoonotic infections [4].
Birds are the main reservoir for C. psittaci [4]. Avian chlamydiosis caused by C. psittaci has
been known for centuries. C. psittaci infections are widespread throughout the world. Based on
isolation, antigen detection, and serology, C. psittaci can infect more than 450 bird species from at
least 30 different orders [5]. The avian host range is probably even broader when diagnosis is made
by PCR, a more sensitive and specific diagnostic technique that has replaced culture as the gold
standard for Chlamydia diagnosis. Consequently, human infection caused by C. psittaci (predominantly
psittacosis and pneumonia) is frequently linked with occupational exposure to infected/colonized
birds. Transmission from animals to humans occurs through inhalation of contaminated aerosols
from urine/feces, respiratory, and eye secretions, for example during cage cleaning or due to bird
bites [4]. However, as suspected also by the present case, transient exposure, for instance by visiting
birds/penguins in wildlife reserves, can also cause chlamydial conjunctivitis.
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Non-chlamydial trachomatis conjunctivitis is rarely reported, and data regarding the prevalence
of C. psittaci in conjunctivitis cases are rare. One study performed in the United States of America
in 1998 found that 20% of patients with chronic conjunctivitis (> 1 month’s duration) who tested
positive for chlamydial lipopolysaccharides (genus-specific LPS) but negative for C. trachomatis-specific
major outer-membrane protein (MOMP), had evidence of C. psittaci DNA in conjunctival samples [6].
Two surveys provide a clue on the prevalence of C. psittaci in trachoma, the chronic form of Chlamydia
ocular infections in Nepal, a trachoma endemic region. C. psittaci was detected in monomicrobial as
well as in mixed Chlamydiaceae infections, in a prevalence ranging from 10–37% [7,8]. Taken together,
these data suggest that ocular infections other than C. trachomatis are probably more common than
expected. Distinction between C. psittaci and C. trachomatis is especially relevant since longer treatment
intervals might be required for C. psittaci ocular infections. While a single dose of azithromycin
1 g is considered adequate for the treatment of C. trachomatis conjunctivitis [9], longer treatment
seems to be necessary for conjunctivitis caused by C. psittaci [6]. Indeed, this patient received
multiple oral (two treatment courses with azithromycin for 3 and 6 days, respectively) and local
(tobramycin/dexamethasone and ofloxacin eye drops) antibiotic courses, before resolution of symptoms
following a 2-week course of doxycycline.
Importantly, C. psittaci conjunctivitis should not be neglected as chronic ocular C. psittaci infections
have been associated with ocular adnexal marginal zone lymphoma (OAMZL) [10,11]. Ferreri et al.
(2012) presented the results of an international phase II trial on the eradication of C. psittaci using
doxycycline as first-line targeted therapy for ocular adnexae lymphoma [12]. Upfront doxycycline
treatment (100 mg orally twice daily for 3 weeks) proved to be a rational and active treatment for
patients with stage I C. psittaci OAMZL. Lymphoma regression was consequent to C. psittaci eradication,
monitored on conjunctival and blood samples.
C. psittaci ocular infection is probably underdiagnosed and therefore underestimated. Currently,
awareness of C. psittaci ocular infection and its clinical presentations is low among general and
occupational physicians, ophthalmologists, and clinicians. Most of the conjunctivitis patients are
managed in primary care, by general practitioners, and current professional guidelines do not
recommend microbial testing for patients with conjunctivitis, and so the patients are treated, but the
causative agent remains unknown.
Several C. psittaci diagnostic tests are available. Culture has several well-known disadvantages,
for instance viable organisms and BSL3 are required, and is therefore seldom performed. Zoonotic
transmission is most often diagnosed by serology. However, C. psittaci serological tests show
cross-reactivity with other chlamydial species and they don’t allow source tracing. In addition,
it may take several weeks to develop a detectable serological response. The patient presented here was
seronegative in the presence of clinical disease and positive by C. psittaci PCR. False seronegative results
are possible during the acute phase of psittacosis [13,14]. Also, a serological response can be negatively
influenced by antibiotic treatment and by genetic variations in Toll-like and/or NOD-like receptors
leading to inadequate recognition of Chlamydia by the hosts immune system [15]. Thus, clinical
decision-making concerning patient management based on serology is unwise and should be avoided.
An increasing number of medical microbiological laboratories are therefore switching to real-time
qPCR. Real-time qPCR is rapid, more sensitive, and more specific than serology [16]. An additional
advantage of real-time qPCR, as also demonstrated here, is that DNA used for the detection of the
pathogen, can also be used for ompA genotyping by use of genotype (A to F and E/B) specific probes [3].
Molecular typing supports source tracing and possible treatment of the infection source which was
not possible in this case as the source most probably originated from the South African wildlife
reserve. Unfortunately, C. psittaci PCR is not yet routinely implemented as National laboratory testing
regulations often require clinical laboratories to be certificated before they can accept clinical samples
for C. psittaci testing by nucleic acid amplification tests (for instance, psittacosis real-time PCR is in the
U.S. not Clinical Laboratory Improvement Amended (CLIA)-validated; https://www.fda.gov/) [17].
Another, perhaps even more important bottleneck for going to nucleic acid amplification tests, is the
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fact that national health insurances reimburse serology, but nucleic acid amplification tests are not
always reimbursed.
In conclusion, in patients with a chronic follicular conjunctivitis that does not respond well to
topical or short oral antibiotic therapy and who report a history of occupational/recreational exposure
to birds (including penguins), a non-chlamydial trachomatis conjunctivitis should be considered.
Diagnosis is to be performed by C. psittaci specific PCR directly on the ocular sample, as C. psittaci
serology can remain negative. A good collaboration between ophthalmologists and the laboratory is
essential to make a proper diagnosis.
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